Rakesh Jhunjhunwala was one of India’s most famous stock market investors, known as the “Big Bull” of Dalal Street. Even after his passing, his team and firm, Rare Enterprises, continue to manage his portfolio.
Many small and big investors still follow his stock picks to understand where smart money is going. In this article, we will share the latest list of companies where Rakesh Jhunjhunwala and Associates have invested. This updated portfolio will help you know which stocks are getting attention from the Big Bull’s team in 2025.
Rakesh Jhunjhunwala and Associates’s Portfolio List
| Stock Name | Market Cap (₹ Cr) | 1Y Return (%) |
|---|---|---|
| Wockhardt Ltd | 22,708.98 | 144.91 |
| Nazara Technologies Ltd | 8,764.69 | 56.76 |
| Fortis Healthcare Ltd | 49,423.34 | 47.16 |
| Indian Hotels Company Ltd | 1,11,931.59 | 36.22 |
| Va Tech Wabag Ltd | 8,511.38 | 36.85 |
| Jubilant Pharmova Ltd | 14,414.10 | 34.26 |
| Federal Bank Ltd | 48,256.65 | 26.00 |
| Jubilant Ingrevia Ltd | 11,000.02 | 24.19 |
| Karur Vysya Bank Ltd | 17,386.66 | 12.93 |
| Edelweiss Financial Services Ltd | 7,662.63 | 8.23 |
| Escorts Kubota Ltd | 36,670.42 | 2.55 |
| CRISIL Ltd | 33,089.14 | 3.92 |
| Metro Brands Ltd | 29,378.46 | 0.72 |
| Concord Biotech Ltd | 16,613.05 | -2.96 |
| Titan Company Ltd | 2,98,508.47 | -5.77 |
| Tata Communications Ltd | 44,733.60 | -9.97 |
| Rallis India Ltd | 4,623.50 | -11.86 |
| Dishman Carbogen Amcis Ltd | 3,231.61 | -11.69 |
| NCC Ltd | 13,295.91 | -14.21 |
| Valor Estate Ltd | 9,549.69 | -19.88 |
| Inventurus Knowledge Solutions Ltd | 24,523.49 | -22.61 |
| Canara Bank Ltd | 87,559.00 | -21.76 |
| Star Health and Allied Insurance Company Ltd | 23,376.27 | -29.45 |
| Tata Motors Ltd | 2,41,220.38 | -34.56 |
| Sun Pharma Advanced Research Co Ltd | 4,860.36 | -44.71 |
Introduction to Rakesh Jhunjhunwala Shares List with Details
Rakesh Jhunjhunwala, known as India’s “Big Bull,” was a legendary investor whose stock picks were closely followed by millions. His portfolio included fundamentally strong companies across sectors like pharma, banking, and infrastructure. Below is a detailed list of stocks he invested in, along with key metrics like market cap, PE ratio, and business model insights.
1. Wockhardt Ltd
- Market Cap: ₹22,708.98 Cr
- PE Ratio: Around 15
Wockhardt is one of India’s leading pharmaceutical companies. It manufactures a wide range of medicines, including generic drugs, vaccines, and biosimilars that are used both in India and internationally.
The company has a strong presence in chronic therapy segments and exports to many countries. Their focus on innovation and quality has helped them grow steadily. The company gave a very good 1-year return of 144.91%, showing strong demand for healthcare products, especially after the pandemic increased the need for medicines and vaccines worldwide.
2. Nazara Technologies Ltd
- Market Cap: ₹8,764.69 Cr
Nazara Technologies is a fast-growing digital entertainment company based in India. They focus mainly on mobile gaming and e-sports, offering games that are popular among young people.
They make money from game sales, in-app purchases, subscriptions, and advertising. The growing popularity of smartphones and affordable internet has helped the company grow fast, leading to a 56.76% return in the last year. Even though the company may not show profits yet, its potential in the fast-expanding gaming market is huge.
3. Fortis Healthcare Ltd
- Market Cap: ₹49,423.34 Cr
- PE Ratio: Around 50
Fortis Healthcare is one of the top hospital chains in India, offering a wide range of medical services like surgeries, diagnostics, and emergency care. Their hospitals are located in many major cities, providing quality healthcare to millions of patients.
Fortis earns revenue through patient care and hospital management services. Despite challenges from the COVID-19 pandemic, increasing healthcare awareness and demand for quality treatment have helped Fortis grow, resulting in a strong 47.16% return in the past year.
4. Indian Hotels Company Ltd
- Market Cap: ₹1,11,931.59 Cr
- PE Ratio: Around 70
Indian Hotels Company Ltd is famous for owning the Taj Hotels, one of India’s most prestigious luxury hotel chains. They provide hospitality services including accommodation, food, and event management.
The hospitality industry faced tough times during the pandemic, but as travel and tourism recover, Indian Hotels has shown strong growth, earning a 36.22% return. Their focus on luxury tourism and international expansion helps maintain a strong market position.
5. Va Tech Wabag Ltd
- Market Cap: ₹8,511.38 Cr
- PE Ratio: Around 40
Va Tech Wabag is a company that provides water treatment and wastewater solutions. They work on projects that help provide clean drinking water and treat sewage water for cities and industries around the world.
Their business mostly involves winning contracts from governments and private companies for large infrastructure projects. With increasing awareness about water conservation and pollution control, Va Tech Wabag has shown a 36.85% return in one year.
6. Jubilant Pharmova Ltd
- Market Cap: ₹14,414.10 Cr
- PE Ratio: 20
Jubilant Pharmova is a pharmaceutical company that produces active pharmaceutical ingredients (APIs) and provides contract research services. Their products are used by drug companies globally to make finished medicines.
The company has a diversified business model, supplying both ingredients and offering research support to other pharma companies. Strong global demand for medicines has helped Jubilant Pharmova grow, with a 34.26% return in the past year.
7. Federal Bank Ltd
- Market Cap: ₹48,256.65 Cr
- PE Ratio: Around 9
Federal Bank is a private sector Indian bank offering a wide range of banking services including savings accounts, loans, and digital banking facilities.
It focuses on retail customers and small businesses, earning mainly through interest income on loans and banking fees. The bank has been steadily growing with increasing use of digital services by customers, delivering a 26% return over the last year.
8. Jubilant Ingrevia Ltd
- Market Cap: ₹11,000.02 Cr
- PE Ratio: Around 30
Jubilant Ingrevia is a specialty chemicals company that produces nutritional ingredients and chemicals used in pharmaceuticals and agriculture.
Their products are sold globally to various industries, making them an important supplier in the supply chain. The company’s focus on innovation and quality has helped it grow steadily, giving a 24.19% return despite some market challenges.
9. Karur Vysya Bank Ltd
- Market Cap: ₹17,386.66 Cr
- PE Ratio: 6
Karur Vysya Bank is a mid-sized private bank focused on retail and small business customers. The bank offers loans, deposits, and other banking services. Its income mainly comes from the interest charged on loans and fees for other banking services.
The bank has shown steady performance with a 12.93% return, supported by increasing banking penetration in smaller towns and rural areas.
10. Edelweiss Financial Services Ltd
- Market Cap: ₹7,662.63 Cr
- PE Ratio: Around 7
Edelweiss is a diversified financial services company offering lending, wealth management, insurance, and asset management services.
It earns revenue through interest on loans and fees from managing assets. The company has grown by expanding its services across India, delivering an 8.23% return in the last year.
11. Escorts Kubota Ltd
- Market Cap: ₹36,670.42 Cr
- PE Ratio: Around 25
Escorts Kubota is a well-known company in India that manufactures tractors and agricultural machinery. It supports farmers by providing equipment that helps improve farm productivity. Their revenue comes mainly from domestic sales but they also export to other countries. Despite modest returns of 2.55%, agriculture remains a strong sector in India and Escorts is a key player.
12. CRISIL Ltd
- Market Cap: ₹33,089.14 Cr
- PE Ratio: 40
CRISIL is India’s leading credit rating and research company. It provides credit ratings, financial research, and risk analysis to banks, investors, and companies. Their business depends on the growth of the financial markets and demand for reliable research. CRISIL had a steady 3.92% return, reflecting stability in its services.
13. Metro Brands Ltd
- Market Cap: ₹29,378.46 Cr
- PE Ratio: 85
Metro Brands owns retail chains selling branded footwear in India. They operate physical stores and e-commerce platforms, earning revenue from sales of shoes and accessories. Despite a small 0.72% return, Metro Brands is expanding in both metro cities and smaller towns, riding on the increasing demand for branded products.
14. Concord Biotech Ltd
- Market Cap: ₹16,613.05 Cr
- PE Ratio: 45
Concord Biotech produces specialty enzymes and bio-based products used in pharmaceuticals and agriculture. Their products help make medicines and fertilizers more efficient. Although the company had a slight negative return of -2.96%, the biotech sector has strong long-term growth potential with increasing global demand.
15. Titan Company Ltd
- Market Cap: ₹2,98,508.47 Cr
- PE Ratio: 45
Titan is a well-known Indian company famous for making watches, jewelry, and eyewear. It earns from selling these consumer products through retail stores and online platforms. Titan has a strong brand presence in India and abroad, which helps it stay strong even during slow markets. Despite a small loss of -5.77%, the company is seen as a reliable long-term investment due to its wide customer base.
16. Tata Communications Ltd
- Market Cap: ₹44,733.60 Cr
- PE Ratio: 40
Tata Communications is a global telecom company providing network and internet services to businesses worldwide. They offer cloud services, data centers, and communication solutions. Despite a negative return of -9.97%, Tata Communications is a key player in India’s digital infrastructure, which is expected to grow strongly with rising internet demand.
17. Rallis India Ltd
- Market Cap: ₹4,623.50 Cr
- PE Ratio: Around 25
Rallis India makes agrochemicals such as pesticides and fertilizers to support Indian farmers. It supplies to both domestic and international markets. Though the company had a negative return of -11.86%, agriculture remains an essential and steady sector in India’s economy with consistent demand.
18. Dishman Carbogen Amcis Ltd
- Market Cap: ₹3,231.61 Cr
- PE Ratio: Around 20
Dishman Carbogen Amcis is a contract manufacturing company that makes pharmaceutical ingredients and medicines for other drug companies. Their business model focuses on providing manufacturing services under contract, helping pharma firms outsource production. The company faced some difficulties leading to -11.69% returns, but it still has good long-term prospects due to steady pharma demand.
19. NCC Ltd
- Market Cap: ₹13,295.91 Cr
- PE Ratio: 15
NCC Ltd is one of India’s major construction and infrastructure companies. It works on building roads, residential projects, and public infrastructure like schools and hospitals. Infrastructure development is key for India’s growth, and though NCC’s stock returned -14.21%, it has many opportunities with government projects.
20. Valor Estate Ltd
- Market Cap: ₹9,549.69 Cr
- PE Ratio: Around 5
Valor Estate is involved in commercial real estate, developing office buildings and retail spaces mainly in metro cities. It earns income through leasing and selling properties. The real estate sector faced some slowdown but is recovering, as seen by the -19.88% return. Valor Estate benefits from urbanisation and growing office space demand.
21. Inventurus Knowledge Solutions Ltd
- Market Cap: ₹24,523.49 Cr
- PE Ratio: Around 30
Inventurus Knowledge Solutions provides research and consulting services focused on the pharmaceutical industry. They help pharma companies with regulatory approvals, market research, and product development. The company had -22.61% returns recently, but its services remain crucial as the pharma industry continues to grow globally.
22. Canara Bank Ltd
- Market Cap: ₹87,559.00 Cr
- PE Ratio: 7
Canara Bank is one of India’s large public sector banks offering savings, loans, and other financial services. It earns mainly through interest on loans and banking fees. Although it had negative returns of -21.76%, ongoing reforms and financial inclusion initiatives are expected to improve its performance in future.
Rakesh Jhunjhunwala was called the “Big Bull” of the Indian stock market Why?
He was a long-term investor with strong belief in India’s growth: Like a bull in the stock market (which means someone who believes prices will rise), Jhunjhunwala always had a positive outlook on the Indian economy and markets.
He made huge profits by investing early in growing companies: He bought shares of companies like Titan, Lupin, Crisil, and others when they were small, and held them for years, turning small investments into crores.
He inspired confidence in others: His moves were closely followed by retail and big investors. When he invested in a stock, people believed it would go up—just like a bull charges ahead.
He was one of the richest and most influential investors in India: At the time of his passing, his net worth from stocks alone was over ₹30,000 crore. This made him one of the biggest individual investors in India.
Top Multibagger Stocks from Rakesh Jhunjhunwala’s Portfolio Based on 5-Year Net Profit Margin
Rakesh Jhunjhunwala and his associates invested in several strong companies, but only a few stand out when we look at their 5-year average net profit margin.
These high-margin businesses often indicate efficient operations and long-term wealth potential. Below is the updated list of the top performers based on this key financial metric.
| Stock Name | 5Y Avg Net Profit Margin % | Market Cap (₹ Cr) |
|---|---|---|
| Concord Biotech Ltd | 29.67% | 16,613.05 |
| Inventurus Knowledge Solutions Ltd | 26.42% | 24,523.49 |
| CRISIL Ltd | 19.34% | 33,089.14 |
| Metro Brands Ltd | 13.68% | 29,378.46 |
| Federal Bank Ltd | 12.50% | 48,256.65 |
| Karur Vysya Bank Ltd | 10.04% | 17,386.66 |
| Escorts Kubota Ltd | 9.73% | 36,670.42 |
| Tata Communications Ltd | 7.56% | 44,733.60 |
| Jubilant Pharmova Ltd | 6.88% | 14,414.10 |
| Titan Company Ltd | 6.75% | 2,98,508.47 |
| Rallis India Ltd | 5.75% | 4,623.50 |
| Canara Bank Ltd | 5.49% | 87,559.00 |
| Fortis Healthcare Ltd | 4.90% | 49,423.34 |
| Va Tech Wabag Ltd | 4.13% | 8,511.38 |
| NCC Ltd | 3.71% | 13,295.91 |
| Nazara Technologies Ltd | 2.73% | 8,764.69 |
| Indian Hotels Company Ltd | -0.61% | 1,11,931.59 |
| Tata Motors Ltd | -1.24% | 2,41,220.38 |
| Dishman Carbogen Amcis Ltd | -1.41% | 3,231.61 |
| Edelweiss Financial Services Ltd | -1.59% | 7,662.63 |
| Star Health and Allied Insurance Co Ltd | -2.96% | 23,376.27 |
| Wockhardt Ltd | -5.63% | 22,708.98 |
| Valor Estate Ltd | -25.50% | 9,549.69 |
Sectors Dominating Rakesh Jhunjhunwala’s Portfolio: Where the Big Bull Placed His Bets
Rakesh Jhunjhunwala and his associates strategically invested across a variety of sectors—from banking to pharma, and telecom to specialty chemicals. The table below highlights the key sectors and industries where his team has major holdings, reflecting a balanced mix of defensive and growth-oriented businesses.
| Stock Name | Sub-Sector | Sector Category |
|---|---|---|
| Titan Company Ltd | Precious Metals, Jewellery & Watches | Consumer Goods |
| Metro Brands Ltd | Footwear | Consumer Goods |
| Indian Hotels Company Ltd | Hotels, Resorts & Cruise Lines | Hospitality |
| Nazara Technologies Ltd | Theme Parks & Gaming | Entertainment & Gaming |
| Tata Motors Ltd | Four Wheelers | Automobile |
| Escorts Kubota Ltd | Tractors | Automobile |
| CRISIL Ltd | Stock Exchanges & Ratings | Financial Services |
| Karur Vysya Bank Ltd | Private Banks | Financial Services |
| Federal Bank Ltd | Private Banks | Financial Services |
| Canara Bank Ltd | Public Banks | Financial Services |
| Edelweiss Financial Services Ltd | Diversified Financials | Financial Services |
| Star Health and Allied Insurance Co Ltd | Insurance | Financial Services |
| Concord Biotech Ltd | Pharmaceuticals | Healthcare |
| Jubilant Pharmova Ltd | Pharmaceuticals | Healthcare |
| Wockhardt Ltd | Pharmaceuticals | Healthcare |
| Sun Pharma Advanced Research Co Ltd | Pharmaceuticals | Healthcare |
| Fortis Healthcare Ltd | Hospitals & Diagnostic Centres | Healthcare |
| Inventurus Knowledge Solutions Ltd | Health Care Equipment & Supplies | Healthcare |
| Dishman Carbogen Amcis Ltd | Labs & Life Sciences Services | Healthcare |
| Jubilant Ingrevia Ltd | Specialty Chemicals | Chemicals |
| Rallis India Ltd | Fertilizers & Agro Chemicals | Chemicals |
| Tata Communications Ltd | Telecom Services | Telecom |
| Va Tech Wabag Ltd | Water Management | Utilities |
| NCC Ltd | Construction & Engineering | Infrastructure |
| Valor Estate Ltd | Real Estate | Real Estate |
Top Dividend Yield Stocks in Rakesh Jhunjhunwala’s Portfolio
Rakesh Jhunjhunwala and his associates have not only focused on growth but also picked select dividend-paying companies. These stocks offer consistent income through dividends, making them attractive for long-term investors who seek regular returns in addition to capital appreciation.
| Stock Name | Dividend Yield (%) |
|---|---|
| Canara Bank Ltd | 3.34 |
| Edelweiss Financial Services Ltd | 1.76 |
| Tata Communications Ltd | 1.59 |
| Sun Pharma Advanced Research Co Ltd | 1.38 |
| CRISIL Ltd | 1.24 |
| Karur Vysya Bank Ltd | 1.11 |
| Rallis India Ltd | 1.05 |
| NCC Ltd | 1.04 |
| Tata Motors Ltd | 0.83 |
| Jubilant Ingrevia Ltd | 0.72 |
| Inventurus Knowledge Solutions Ltd | 0.70 |
| Federal Bank Ltd | 0.61 |
| Concord Biotech Ltd | 0.55 |
| Jubilant Pharmova Ltd | 0.55 |
| Escorts Kubota Ltd | 0.54 |
| Metro Brands Ltd | 0.46 |
| Titan Company Ltd | 0.33 |
| Indian Hotels Company Ltd | 0.22 |
| Fortis Healthcare Ltd | 0.15 |
Net Worth of Rakesh Jhunjhunwala and Rekha Jhunjhunwala
Rakesh Jhunjhunwala, also known as the “Big Bull of India,” had a net worth of around $5.8 billion when he passed away in August 2022. He was among the richest people in the world, ranked 438th globally. After his death, his wife, Rekha Jhunjhunwala, took over his investments and wealth. As of October 2024, she is one of the richest individuals in India, holding the 28th position on Forbes’ list of India’s top 100 richest, with a net worth of $9.3 billion.
Advantages of Investing in Rakesh Jhunjhunwala’s Portfolio Stocks
Investing in Rakesh Jhunjhunwala and Associates’s portfolio offers many benefits. The portfolio is well-diversified across sectors like banking, pharma, telecom, and consumer goods, reducing sector-specific risks. It includes both stable blue-chip stocks and high-growth mid-cap stocks, offering a balance of safety and growth potential. Many of these companies have strong financials and a history of performance, which gives investors confidence in long-term returns. Some stocks also offer regular dividends, adding extra income. Most importantly, following the investment path of a legendary investor brings valuable strategic insights to any portfolio.
FAQs – Rakesh Jhunjhunwala and Associates’s Portfolio
Who was Rakesh Jhunjhunwala?
He was a famous Indian stock market investor, known as the “Big Bull of India,” with a sharp eye for multibagger stocks.
Who manages his portfolio now?
After his passing in 2022, his wife Rekha Jhunjhunwala manages the investments.
What is Rekha Jhunjhunwala’s net worth now?
As of October 2024, her net worth is around $9.3 billion, according to Forbes.
Which are some top-performing stocks in his portfolio?
Stocks like Concord Biotech, CRISIL, Titan, and Metro Brands have performed well over the past five years.
Are there high dividend stocks in his portfolio?
Yes, stocks like Canara Bank, Edelweiss, and Tata Communications offer decent dividend yields.
Which sectors dominate the portfolio?
Key sectors include pharmaceuticals, private banks, telecom, healthcare, and construction.
Are his stocks suitable for long-term investment?
Yes, many stocks have strong fundamentals and long-term growth potential.
Why should investors consider this portfolio?
It offers sector diversification, proven company performance, dividend income, and follows the strategy of a legendary investor.
Do all stocks give good returns?
Not all. Some have underperformed, but overall the portfolio is balanced for long-term gains.
Where can I track these stocks?
You can check updates on stock market websites like NSE, BSE, Moneycontrol, or economic news portals.